2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association

SS Martin, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Heart disease and stroke statistics—2023 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Mendelian randomization as a tool for cardiovascular research: a review

MG Levin, S Burgess - JAMA cardiology, 2024 - jamanetwork.com
Importance Mendelian randomization (MR) is a statistical approach that has become
increasingly popular in the field of cardiovascular disease research. It offers a way to infer …

Robust multivariable Mendelian randomization based on constrained maximum likelihood

Z Lin, H Xue, W Pan - The American Journal of Human Genetics, 2023 - cell.com
Mendelian randomization (MR) is a powerful tool for causal inference with observational
genome-wide association study (GWAS) summary data. Compared to the more commonly …

Prioritizing the role of major lipoproteins and subfractions as risk factors for peripheral artery disease

MG Levin, V Zuber, VM Walker, D Klarin, J Lynch… - Circulation, 2021 - Am Heart Assoc
Background: Lipoprotein-related traits have been consistently identified as risk factors for
atherosclerotic cardiovascular disease, largely on the basis of studies of coronary artery …

Causal association of cardiovascular risk factors and lifestyle behaviors with peripheral artery disease: a Mendelian randomization approach

AG Hoek, S van Oort, PJM Elders… - Journal of the American …, 2022 - Am Heart Assoc
Background We investigated the causal associations between the genetic liability to
cardiovascular and lifestyle risk factors and peripheral artery disease (PAD), using a …

Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations

B Fan, JV Zhao - BMC medicine, 2024 - Springer
Background Mental disorders are among the top causes of disease burden worldwide.
Existing evidence regarding the repurposing of antihypertensives for mental disorders …

Sex and Racial Disparities in Peripheral Artery Disease

S Divakaran, AK Krawisz, EA Secemsky… - … , and Vascular Biology, 2023 - Am Heart Assoc
Several studies have shown that women and racial and ethnic minority patients are at
increased risk of developing lower extremity peripheral artery disease and suffering adverse …

Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian …

JV Zhao, F Liu, CM Schooling, J Li, D Gu, X Lu - Diabetologia, 2022 - Springer
Aims/hypothesis Diabetes and hyperlipidaemia are common comorbidities in people with
hypertension. Despite similar protective effects on CVD, different classes of antihypertensive …

Inflammatory and prothrombotic biomarkers, DNA polymorphisms, microRNAs and personalized medicine for patients with peripheral arterial disease

P Poredoš, M Šabovič, M Božič Mijovski… - International Journal of …, 2022 - mdpi.com
Classical risk factors play a major role in the initiation and development of atherosclerosis.
However, the estimation of risk for cardiovascular events based only on risk factors is often …